A spokesman for the Chinese Embassy in the United States answered a reporter's question on US sanctions against Chinese entities and individuals on the grounds of participating in illegal drug production. According to the website of the Chinese Embassy in the United States, a spokesman for the Chinese Embassy in the United States answered a reporter's question on US sanctions on Chinese entities and individuals on the grounds of participating in illegal drug production. Q: on May 30, the US Treasury announced sanctions against 13 Chinese entities and individuals on the grounds of participating in the cross-border sale of illegal drug production equipment. Does the spokesman have any comment on this? A: on the one hand, the United States repeatedly hopes that China will resume drug control cooperation, and on the other hand, it flagrantly sanctions Chinese entities and individuals again, seriously infringing upon the legitimate rights and interests of relevant enterprises and individuals. The Chinese side strongly condemns this. The US side's excuse for imposing the sanctions is that these Chinese entities and individuals sell pressing machines, moulds and other equipment to the United States and Mexico. As we all know, tablet machines and moulds are common commodities, have legitimate uses, and are widely used in normal industrial production. And according to international practice and common practice, ensuring that international goods are not used for illegal purposes is not only the basic responsibility of the importing enterprise, but also the legal obligation of the government of the importing country. China has always been strict in drug control and, in the spirit of humanitarianism, has been doing its best to help the United States deal with the fentanyl issue. In May 2019, China took the lead in the global control of fentanyl substances, which played an important role in preventing its illegal manufacture, trafficking and abuse. However, the US side not only ignores the goodwill of the Chinese side, but insists on unreasonably sanctioning the material evidence Identification Center of the Chinese Ministry of Public Security, the national drug laboratory, and other institutions on the grounds of the so-called human rights issue in Xinjiang, and is now repeatedly sanctioning Chinese enterprises and individuals. "throwing the pot" at the Chinese side has seriously undermined the basis of drug control cooperation between the two sides. The root of the drug epidemic in the United States lies in the United States itself. The United States, which accounts for only 5% of the world's population, consumes 80% of the world's opioids, and so far there is no permanent category of fentanyl. With the increasingly stringent control of fentanyl-like substances in the international community and China, the problem of fentanyl in the United States continues to deteriorate, and the death toll is rising instead of falling. The United States should reflect deeply on this. Instead of reducing domestic drug demand, strengthening the control of prescription drugs, and strengthening publicity and education on drug harm, the US side has arbitrarily waved a big stick of sanctions against other countries in an attempt to confuse the public, mislead the public, and pass on its own responsibility for poor governance. The American people and the international community are well aware of this. The sanctions imposed by the United States on Chinese enterprises and citizens will create further obstacles to Sino-US drug control cooperation and harm others and themselves. If the US side sincerely wants to solve the domestic drug problem, it should respect the facts, reflect on itself, correct mistakes, and stop blaming the blame. China will continue to take necessary measures to safeguard the legitimate rights and interests of Chinese enterprises and individuals.